Table 2.
Features of patients included in the retrospective analysis at baseline and after 6 months of treatment; * p < 0.05; *** p < 0.001.
| Analyses | Baseline Values | Values after 6 Months of DCI Treatment | p-Values |
|---|---|---|---|
| BMI (Kg/m2) | 28.00 [26.75–29.25] | 26.00 [25.00–26.25] | 0.00044 *** |
| Glycemia (mg/dL) | 105.00 [103.50–107.25] | 99.00 [95.75–101.25] | 0.00024 *** |
| Insulinemia (μIU/mL) | 21.00 [18.00–24.25] | 15.50 [13.00–18.25] | 0.00008 *** |
| HOMA-IR index | 4.40 [3.70–4.93] | 3.00 [2.45–3.50] | 0.00008 *** |
| FSH (mIU/mL) | 7.00 [4.75–10.00] | 6.95 [4.88–8.05] | 0.57549 |
| LH (mIU/L) | 7.80 [5.68–10.08] | 5.80 [4.90–7.43] | 0.01596 * |
| Total T (ng/mL) | 0.63 [0.33–0.80] | 0.37 [0.11–0.50] | 0.00010 *** |
| Estradiol (pg/mL) | 43.50 [36.75–74.25] | 62.00 [51.50–71.75] | 0.03318 * |
| DHEAS (μg/dL) | 96.50 [74.25–166.75] | 79.50 [57.75–126.25] | 0.00024 *** |
| Menstrual irregularity | 4 patients | 16 patients | OR = 16.00; 95% CI [3.40–75.35] |